Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium.

family history gastric cancer international consortium meta-analyses

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Jul 2021
Historique:
received: 21 06 2021
revised: 14 07 2021
accepted: 15 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 8 8 2021
Statut: epublish

Résumé

Although there is a clear relationship between family history (FH) and the risk of gastric cancer (GC), quantification is still needed in relation to different histological types and anatomical sites, and in strata of covariates. The objective was to analyze the risk of GC according to first-degree FH in a uniquely large epidemiological consortium of GC. This investigation includes 5946 cases and 12,776 controls from 17 studies of the Stomach Cancer Pooling (StoP) Project consortium. Summary odds ratios (OR) and the corresponding 95% confidence intervals (CIs) were calculated by pooling study-specific ORs using fixed-effect model meta-analysis techniques. Stratified analyses were carried out by sex, age, tumor location and histological type, smoking habit, socioeconomic status, alcohol intake and fruit consumption. The pooled OR for GC was 1.84 (95% CI: 1.64-2.04; I2 = 6.1%, P heterogeneity = 0.383) in subjects with vs. those without first-degree relatives with GC. No significant differences were observed among subgroups of sex, age, geographic area or study period. Associations tended to be stronger for non-cardia (OR = 1.82; 95% CI: 1.59-2.05 for subjects with FH) than for cardia GC (OR = 1.38; 95% CI: 0.98-1.77), and for the intestinal (OR = 1.92; 95% CI: 1.62-2.23) than for the diffuse histotype (OR = 1.62; 95% CI: 1.28-1.96). This analysis confirms the effect of FH on the risk of GC, reporting an approximately doubled risk, and provides further quantification of the risk of GC according to the subsite and histotype. Considering these findings, accounting for the presence of FH to carry out correct prevention and diagnosis measures is of the utmost importance.

Identifiants

pubmed: 34359744
pii: cancers13153844
doi: 10.3390/cancers13153844
pmc: PMC8345354
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Jpn J Clin Oncol. 2002 Aug;32(8):284-90
pubmed: 12411565
Carcinogenesis. 1999 Dec;20(12):2195-208
pubmed: 10590210
Cancer Causes Control. 2004 Feb;15(1):67-72
pubmed: 14970736
Jpn J Clin Oncol. 2002 Aug;32(8):277-83
pubmed: 12411564
Am J Epidemiol. 2006 Jun 1;163(11):1053-64
pubmed: 16624970
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):73-80
pubmed: 10667466
Gastroenterology. 2001 Dec;121(6):1286-93
pubmed: 11729107
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 2002 Feb 10;97(5):688-94
pubmed: 11807799
Occup Environ Med. 2012 Apr;69(4):268-75
pubmed: 22068174
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):15-8
pubmed: 8118379
Gastroenterol Res Pract. 2020 Oct 22;2020:4028136
pubmed: 33144855
Eur J Cancer Prev. 2007 Aug;16(4):312-27
pubmed: 17554204
Gastric Cancer. 2018 Sep;21(5):729-737
pubmed: 29455268
Int J Cancer. 1995 Mar 16;60(6):748-52
pubmed: 7896439
Cancer Causes Control. 2011 May;22(5):725-36
pubmed: 21347819
Biomed Res Int. 2013;2013:385132
pubmed: 23484115
Int J Cancer. 2005 Oct 10;116(6):972-83
pubmed: 15856451
Br J Cancer. 2010 Jan 19;102(2):237-42
pubmed: 19888225
Gastric Cancer. 2004;7(1):46-53
pubmed: 15052440
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Eur J Cancer Prev. 2003 Jun;12(3):183-9
pubmed: 12771555
Korean J Intern Med. 2016 Nov;31(6):1042-1053
pubmed: 27809451
Eur J Cancer. 2009 Nov;45(16):2867-73
pubmed: 19427197
Jpn J Cancer Res. 2001 Aug;92(8):829-35
pubmed: 11509113
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408
pubmed: 23697611
Int J Cancer. 2003 Nov 20;107(4):629-34
pubmed: 14520702
Gastroenterol Clin North Am. 2013 Jun;42(2):219-40
pubmed: 23639638
Eur J Cancer Prev. 2000 Dec;9(6):401-8
pubmed: 11201678
Int J Cancer. 2009 Oct 15;125(8):1953-60
pubmed: 19569234
Lancet Gastroenterol Hepatol. 2018 Dec;3(12):874-883
pubmed: 30507471
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):591-603
pubmed: 29579788
Clin Epidemiol. 2018 Sep 04;10:1169-1179
pubmed: 30233251
Cancer Causes Control. 2009 Apr;20(3):361-8
pubmed: 18989634
Int J Cancer. 1999 Aug 12;82(4):473-6
pubmed: 10404057
Eur J Cancer Prev. 2015 Jan;24(1):16-23
pubmed: 24566154
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680
BMC Cancer. 2012 Oct 25;12:494
pubmed: 23098561
BMC Cancer. 2009 Sep 28;9:346
pubmed: 19785726
Int J Cancer. 2008 Sep 15;123(6):1429-32
pubmed: 18567000
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Facundo Vitelli-Storelli (F)

Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.

María Rubín-García (M)

Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.

Claudio Pelucchi (C)

Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy.

Yolanda Benavente (Y)

Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Rossella Bonzi (R)

Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy.

Matteo Rota (M)

Department of Molecular and Translational Medicine, University of Brescia, 25121 Brescia, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, 08518 Florence, Italy.

Monica Ferraroni (M)

Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy.

Nuno Lunet (N)

EPIUnit-Instituto de Saúde Pública da Universidade do Porto, 4050-091 Porto, Portugal.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal.

Samantha Morais (S)

EPIUnit-Instituto de Saúde Pública da Universidade do Porto, 4050-091 Porto, Portugal.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal.

Weimin Ye (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.

Amelie Plymoth (A)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden.

Reza Malekzadeh (R)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.

Shoichiro Tsugane (S)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo 104-0045, Japan.

Akihisa Hidaka (A)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo 104-0045, Japan.

Nuria Aragonés (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Cancer Epidemiology Section, Public Health Division, Department of Health of Madrid, 28035 Madrid, Spain.

Gemma Castaño-Vinyals (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Department of Public health, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain.
Barcelona Institute for Global Health-ISGlobal, 08036 Barcelona, Spain.

David Georgievich Zaridze (DG)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, 115478 Moscow, Russia.

Dmitry Maximovich (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, 115478 Moscow, Russia.

Jesus Vioque (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL-UMH, 46020 Alicante, Spain.

Manuela García-de-la-Hera (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL-UMH, 46020 Alicante, Spain.

Zuo-Feng Zhang (ZF)

Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095-6900, USA.

Gerson Shigueaki Hamada (G)

Nikkei Disease Prevention Center, São Paulo 13010-111, Brazil.

Mohammadreza Pakseresht (M)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.
Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Nutritional Epidemiology Group, Centre for Epidemiology and Biostatistics, University of Leeds, Leeds LS2 9JT, UK.

Farhad Pourfarzi (F)

Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.
Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil 56189-85991, Iran.

Lina Mu (L)

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY 14261, USA.

Stefania Boccia (S)

Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 20123 Rome, Italy.
Department of Woman and Child Health and Public Health-Public Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Roberta Pastorino (R)

Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 20123 Rome, Italy.

Guo-Pei Yu (GP)

Medical Informatics Center, Peking University, Beijing 100191, China.

Areti Lagiou (A)

Department of Public and Community Health, School of Public Health, University of West Attica, 12243 Athens, Greece.

Pagona Lagiou (P)

Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 01451, USA.

Eva Negri (E)

Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, University of Milan, 20133 Milan, Italy.

Vicente Martín (V)

Grupo de Investigación en Interacciones Gen-Ambiente y Salud (GIIGAS), Institute of Biomedicine (IBIOMED), University of León, 24071 León, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Classifications MeSH